Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker StudyRobert Wesolowski, Bhuvaneswari Ramaswamy, Maryam B. Lustberg et al.|The Oncologist|2020Cited by 14